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Introduction
Approximately 40 million people are infected with the
human immunodeﬁciency virus (HIV) worldwide (UNA-
IDS 2006). Infections by this lentivirus from the family
Retroviridae are characterized by a long asymptomatic
period after host immune defenses control the initial
infection. During this subsequent chronic phase of infec-
tion, HIV slowly diminishes the host’s immune function-
ing by targeting CD4+ T lymphocytes for infection.
Within these cells the virus replicates by hijacking the
intracellular molecular machinery to transcribe viral RNA,
and eventually the productively infected cells die (Fauci
1988). Over time, the density of virions in the blood
stream increases and the immune system functioning
becomes progressively compromised, leaving HIV-infected
individuals increasingly susceptible to opportunistic infec-
tions.
Being blood-borne, HIV is transmitted via contact with
the blood of an infected individual: through transfusions,
needle-sharing, sexual contact or from mother to child
during childbirth or breast-feeding. Initially there were
concerns that HIV might be vector-borne (e.g., transmit-
ted via mosquitoes) but it has since become widely
accepted that such transmission does not occur at any
signiﬁcant level (Bockarie and Paru 1996). This current
belief stems both from epidemiological data and experi-
mental studies that directly examine the potential for
HIV transmission via arthropods (Lawrence 1987; Lifson
1988; Bockarie and Paru 1996).
Why is HIV not vector-borne (throughout this article
we use the term ‘vector’ synonymously with ‘arthropod’)?
The majority of medical scientists, when asked this ques-
tion, will offer the following explanations (Bockarie and
Paru 1996): (i) HIV concentrations in the blood are too
low during human infection to permit vector transmis-
sion; (ii) HIV is unable to survive long enough outside of
humans (or primates) for vector transmission; (iii) HIV
is not able to replicate within arthropod vectors. Each of
these explanations has empirical support (Lifson 1988;
Bockarie and Paru 1996) and thus all three are good
explanations for the lack of vector transmission in HIV.
If most arthropods pick up very little HIV when feeding
on humans, and if the level of HIV in (or on) these
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Abstract
Many pathogens of humans are blood borne, including HIV, Malaria, Hepatitis
B and C, West Nile virus, Dengue, and other viral hemorrhagic fevers.
Although several of these pathogens are transmitted by blood-feeding arthro-
pods, HIV is not. A number of properties of HIV and its life cycle have been
identiﬁed as proximate explanations for the absence of arthropod transmission,
but little consideration has been given to why HIV has not evolved this form
of transmission. We consider the empirical evidence for arthropod transmis-
sion, and suggest that mechanical transmission has not evolved in HIV because
such strains would induce a faster onset of AIDS during infection, which would
thereby limit their ability to spread. On the other hand, it is not as clear why
biological transmission has not occurred. Available data suggests that a lack of
appropriate genetic variation in HIV is one explanation, but it is also possible
that a conﬂict between natural selection occurring within and between infected
individuals has prevented its evolution instead. We discuss the potential signiﬁ-
cance of these ideas, and argue that taking such an evolutionary perspective
broadens our understanding of infectious diseases and the potential conse-
quences of public health interventions.
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mission is expected to occur.
The above ﬁndings provide a satisfying proximate
explanation for the lack of vector transmission in HIV.
Given the current characteristics of HIV, these three fea-
tures of the virus make it unlikely that vector transmis-
sion will occur. In this article, we approach this question
from an evolutionary perspective. Therefore, rather than
taking the characteristics of HIV as given, we are inter-
ested in understanding why HIV has evolved these partic-
ular features and not others instead. For example: (i) why
has HIV not evolved a replication strategy that results in
viral concentrations high enough to allow vector trans-
mission? (ii) why has HIV not evolved to be more dura-
ble and thus to survive longer outside of humans? (iii)
why has HIV not evolved the ability to replicate in
arthropod vectors?
Asking such questions might strike many readers as
strange since much of evolutionary biology proceeds by
asking why certain features of organisms are as we
observe them rather than by asking why some features
are absent. This is only natural, since it is difﬁcult to
decide which, among the inﬁnite number of ‘missing fea-
tures’, should be the focus of study. It is useful to view
such questions as falling on a continuum, from questions
about the lack of traits that are virtually non-existent in
all taxa (e.g., why do dogs not have wheeled appendages)
to questions about the lack of traits that are common in
some populations or species but not others (e.g., why do
German Shepherds not have curly hair?). Our contention
is that, by asking such questions about the absence of
some traits, we can gain deeper insight into biology. To
quote philosopher Arthur Eddington (1927), ‘‘…the con-
templation in natural science of a wider domain than the
actual leads to a far better understanding of the actual.’’.
As in all science, however, not all questions are inter-
esting, and this serves as our primary guide for focusing
on some missing features and not others. In particular,
we focus on the lack of vector transmission in HIV,
because of the profound epidemiological signiﬁcance of
its absence. An arthropod-transmissible form of HIV
would clearly exacerbate the already devastating impact of
the disease, opening up routes of transmission to groups
previously at low-risk (e.g., children). Therefore, it is
worth asking why, from an evolutionary standpoint, this
has not occurred (Weiss 2001). More to the point, if
there are conditions under which HIV could have evolved
vector transmission we would do well to understand
these, not only from the standpoint of scientiﬁc curiosity,
but also to prevent such an outcome in the future.
In this article, we address the question of why HIV
lacks vector transmission, both through a consideration
of available empirical data and through the construction
of mathematical models. Although our results are neces-
sarily speculative, we believe that they shed some light on
the evolutionary biology of HIV, and on the evolutionary
biology of blood-borne pathogens more generally.
Why is HIV not vector-borne?
There are two broad reasons why a trait of interest (in
this case vector-transmission) might not evolve. First, the
necessary genetic variation for the trait might arise only
very rarely (if at all). For instance, the evolution of RNA
viruses, such as HIV, could be strongly constrained by
the size of their genome (Holmes 2003). Second, the nec-
essary form and strength of natural selection might not
be present for the trait to evolve, at least over the time-
scale under consideration. Thus, from an evolutionary
standpoint, HIV is not vector-borne because either the
necessary genetic variation for such transmission has
never arisen, or the necessary selective factors that would
make such variants increase in frequency over the relevant
timescale have not occurred. Our evolutionary explana-
tion for why HIV is not vector-borne will be sought
within these two possibilities.
Before beginning to consider these explanations, we
must be more precise about our deﬁnition of vector-
transmission. There are two different processes that might
result in vector-transmission, and that are often lumped
under this single heading. The ﬁrst is simple mechanical
transmission of a pathogen by arthropods. This occurs
when the arthropod acts solely as a means of physical
transport of viral particles between hosts (e.g., having
viral particles in and around mouthparts). The second is
biological transmission. This occurs when the virus repli-
cates within the arthropod vector during the time period
between feeding events.
Genetic variation
How likely is it that HIV has not evolved vector transmis-
sion because of a lack of appropriate genetic variation?
The most direct way to assess this possibility is to deter-
mine if genetic variants capable of vector transmission are
currently present in the HIV population. Unfortunately,
performing such an assay on all genotypes within the
population would be next to impossible. Furthermore, if
variants capable of vector transmission are selectively dis-
advantageous, then their frequency in the population
might be extremely low. Nevertheless, there are some
studies available that take this approach as far as is
possible.
A second approach to addressing this issue is to exam-
ine the closely related viruses of HIV. If some of HIVs
close relatives have evolved vector-transmission, then the
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sion in HIV does not exist would be signiﬁcantly weak-
ened. Below we review both types of evidence, for both
mechanical and biological transmission.
Mechanical transmission: A number of studies working
directly with HIV have assayed its ability to be transmit-
ted mechanically by arthropods. Such transmission is often
difﬁcult to assess under natural conditions, and therefore
most studies have employed artiﬁcial experimental setups,
using a variety of arthropods including mosquitoes, stable
ﬂies, and Tabanids (e.g., horse ﬂies and deer ﬂies).
Although the ﬁndings are somewhat mixed, mechanical
transmission appears possible in principle. For example,
HIV was found to be viable for up to 10 days in African soft
ticks, and perhaps even up to 14 days (Humphrey-Smith
et al. 1993; see also Humphrey-Smith and Chastel 1988).
Likewise, Webb et al. 1989 found that HIV can remain
infectious for up to 8 days in the gut of Cimex hemipterus.
Most research on this topic has stressed the need for large
bloodmeal size, however, because HIV tends not to have a
very high viral titre during infection in humans (Lifson
1988; Webb et al. 1989; Foil and Issel 1991; Bockarie and
Paru 1996). This has led to a focus on arthropods, like
ticks, whose bloodmeal sizes are often 70 times larger than
that of mosquitoes (Humphrey-Smith et al. 1993). It has
also been suggested that squashing mosquitoes while they
are feeding, and subsequently scratching the area (which
might result in lacerations) could increase the likelihood of
transmission as well (Siemens 1987).
Other studies of closely related viruses suggest that, in
principle, there is no obvious barrier to mechanical trans-
mission of HIV by arthropods. In fact, it has also been
suggested that mechanical vector transmission might be
the route through which HIV was initially transmitted to
humans (Eigen et al. 2002). At least three other retro-
viruses can be transmitted mechanically, including Bovine
leukemia virus, Friend murine leukemia virus, and equine
infectious anemia virus (Foil and Issel 1991; Humphrey-
Smith et al. 1993). The latter (equine infectious anemia
virus) is believed to be a close relative of HIV (McClure
et al. 1988), and epidemiological evidence suggests that
vector transmission might play a signiﬁcant role in its
transmission (Foil and Issel 1991). Interestingly, however,
all three of these retroviruses tend to reach viral titres in
their hosts that are much higher than those typical of
HIV (Foil and Issel 1991).
It has also been suggested that some Hepatitis viruses
can be transmitted mechanically by arthropods (Jupp
et al. 1983), although this has been controversial (Kuno
2004). Even if this does occur, however, the viral levels of
HIV in humans are thought to be about 10 to 100 times
lower than that of some hepatitis viruses (Foil and Issel
1991), again implicating HIVs low titre during infection
of humans as the primary reason that mechanical trans-
mission does not occur in this virus.
Biological transmission: Despite evidence that mechani-
cal transmission of HIV by arthropods can occur, there
is no evidence that biological transmission is possible.
For example, although Humphrey-Smith et al. (1993)
found that HIV can remain viable in ticks for up to
2 weeks, they failed to ﬁnd any evidence that HIV can
replicate in these vectors. Evidence has been reported of
HIV-related nucleic acids being found in Tsetse ﬂies
from central Africa (Becker et al. 1986), but this has
been controversial, and epidemiological evidence is not
indicative of vector transmission (Noireau et al. 1987).
Furthermore, experiments using cell cultures from
arthropods have demonstrated that HIV is not capable
of replicating in these cells (Srinivasan et al. 1987). In
fact, no evidence exists to date that any retrovirus is
capable of biological transmission by arthropods (Webb
et al. 1989; Foil and Issel 1991; Kuno 2004; Kuno and
Chang 2005). It remains unclear exactly why such repli-
cation is not possible, but functional constraints on
receptor use in arthropods versus mammals provides
one proximate explanation (van den Heuvel et al. 1999).
Alternatively, it remains possible that appropriate genetic
variation can arise, but that selection simply does not
favor the spread of biological transmission in HIV or
other retroviruses.
Selection
The above empirical ﬁndings suggest that, in principle,
HIV is capable of being transmitted mechanically. In
practice, however, the typical HIV viral titre in the
bloodstream of humans is too low for signiﬁcant vector-
borne transmission to occur (Lifson 1988; Webb et al.
1989; Foil and Issel 1991; Bockarie and Paru 1996).
There is evidence of genetic variation for differences in
viremia in HIV-infected patients (Kanki et al. 1999) and
this therefore suggests that mechanical transmission
should be evolutionarily feasible if it were selectively
advantageous. Thus, we are forced to ask: why have
genetic variants of HIV that induce higher viremia, and
thus that transmit mechanically via arthropods, not
increased in frequency?
On the other hand, there is no evidence to suggest that
biological transmission can occur, even in principle. This
might be because the relevant genetic variation for such
transmission has not appeared (or perhaps is not possi-
ble). Alternatively, perhaps such variation does occasion-
ally arise, but that such strains are acted against by
natural selection. In this section we use some mathemati-
cal calculations to elucidate potential reasons why selec-
tion might not favor increased viremia and thus
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the same question for biological transmission.
Mechanical transmission: To understand the form and
strength of selection shaping the evolution of HIV vire-
mia it is helpful to quantify the important properties of
HIV epidemiology in terms of a mathematical model. At
present HIV infection is increasing in prevalence in the
human population (UNAIDS 2006). The simplest descrip-
tion of this is exponential growth in the number of
infected individuals;
dy
dt
¼ ry ð1Þ
where y(t) is the number of HIV-positive individuals at
time t, and r is the per capita growth rate. Although the
rate of increase of HIV appears to be slowing in recent
years, exponential growth nevertheless provides a useful
benchmark for its initial spread in humans.
The per capita growth rate will depend on various
properties of HIV, including its mode of transmission. To
derive an expression for the per capita growth rate of
HIV-positive individuals in terms of underlying epidemi-
ological parameters, we ﬁrst need to specify a model for
the epidemiological dynamics. This model will allow for
both sexual transmission of HIV as well as insect trans-
mission, and therefore it will also track the number of
insects carrying HIV. Using w(t) for the number of
insects carrying HIV at time t, and y(a,t) as the number
of HIV-positive people who were infected a years ago, we
specify the dynamics as
dwðtÞ
dt
¼ vab1
Z 1
0
yðs;tÞds   lwðtÞð 2aÞ
@yða;tÞ
@t
¼ 
@yða;tÞ
@a
  dðaÞyða;tÞð 2bÞ
with boundary condition yð0;tÞ¼xab2wðtÞþxb R 1
0 yðs;tÞds. In equations (2), v is the population size of
insects free of HIV, a is the insect-biting rate, b1 is the
probability of an insect picking up HIV, given it feeds on
an infected human, and l is the per capita loss rate of
infected insects (which subsumes both insect mortality and
the decay of HIV stores in or on the insect). Note that,
although many insects display a characteristic time lag
between feeding events, for simplicity we have ignored this.
Also note that, for simplicity, equations (2) implicitly
assume that the likelihood of an insect picking up HIV
from an infected human is constant across all infection ages
(i.e., it does not depend on a). The parameter b2 is the
probability that an insect-carrying HIV infects a human
when feeding, and x is the number of HIV-negative people.
We assume that the number of susceptible insects and peo-
ple are both constant over the timescale of interest because
HIV infection is still increasing in prevalence in the human
population (UNAIDS 2006). The parameter b is the trans-
mission rate through sexual contact of HIV, and is assumed
to be independent of infection age. Our assumption is justi-
ﬁed on the basis that we are concerned with average vire-
mia throughout the entire infection, and viral loads during
the acute infection phase are strongly correlated with viral
loads during the subsequent chronic phase (Kelley et al.
2007). Results in Appendix 1 also show that the main con-
clusions are not altered by relaxing this assumption. Lastly,
d(a) is a function describing the mortality rate of HIV-
positive people as a function of infection age. In particular,
we will suppose that d(a) has the form
dðzÞ¼ d0 z<s
1 z   s
 
ð3Þ
where s is the time during the infection at which AIDS
develops.
This model is analyzed in Appendix 1 to show that the
asymptotic per capita rate of increase, r, is deﬁned implic-
itly, as a function of various epidemiological parameters,
by the equation:
r þ d0 ¼ x
va2b1b2
l
þ b
  
1   e ðrþd0Þs
  
: ð4Þ
Some of the parameters in equation (4) will depend on
the level of viremia in humans, and therefore viremia will
affect the per capita rate of spread of HIV. In particular,
the amount of HIV picked up by an arthropod during a
feeding, b1, is expected to increase with viremia. Similarly,
evidence suggests that sexual transmission rate, b, also
increases with viremia (Operskalski et al. 1997; Tovanabu-
tra et al. 2002; Wawer et al. 2005). Lastly, evidence also
shows that high levels of viremia lead to a more rapid
development of AIDS, and thus a lower value of s in
untreated patients (Mellors et al. 1997; Levy 1998; Raffanti
et al. 2004).
With these speciﬁcations, our question about the evo-
lution of mechanical transmission of HIV can now be
cast in population-genetic terms. Suppose the predomi-
nant strain of HIV is one that gives rise to a viremia too
low for vector transmission (i.e., b1   0). Also suppose
that a mutant strain arises that produces a viremia high
enough for mechanical vector transmission. Assuming
that multiple infections do not occur (an assumption that
we relax below), the rate of change in frequency, p, of this
mutant strain is (Day and Gandon 2007)
dp
dt
¼ p 1   p ðÞ rB   rA ðÞ ð 5Þ
where rA is the per capita growth rate of the original
strain and rB is the per capita growth rate of the mutant
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equation (4), as
rA þ d0   xb 1   e ðrAþd0ÞsA
  
; ð6aÞ
and
rB þ d0   x
va2b1b2
l
þ b
  
1   e ðrBþd0ÞsB
  
; ð6bÞ
respectively. Equations (6) make the implicit assumption
that the increased viremia of the mutant strain does not
signiﬁcantly increase its sexual transmission rate. More
precisely, sexual transmission must be a concave function
of viremia with an optimal viral load that is lower than
for vector transmission for the following argument to
hold. Empirical evidence in support of this functional
form for HIV exists (Quinn et al. 2000; Fraser et al. 2007).
Two qualitatively distinct evolutionary outcomes are
predicted depending upon parameter values (Fig. 1).
First, a comparison of equations (6a) and (6b) reveals
that rB will be smaller than rA (i.e., the mutant strain will
decrease in frequency) and HIV will be predominately
sexually transmitted, when the following conditions hold:
vector mortality, or the HIV decay rate, is high (i.e., large
l), vector population size is small (i.e., small v), vector
biting rate is small (i.e., small a), or the HIV transfer
rates to and from vectors, b1 and b2, are small. Indeed, rB
is not only less than rA in such situations (as in Fig. 1),
but often negative as well, meaning that vector transmissi-
ble strains will not only decrease in frequency but in
absolute numbers. Therefore, some or all of the above
conditions must hold if this analysis is to explain why
HIV has not evolved mechanical vector transmission.
Conversely, if the opposite conditions hold, then the
mutant will increase in frequency, and both sexual and
mechanical vector transmission will play a signiﬁcant role
in the disease’s epidemiology (Fig. 1).
These considerations provide the conditions required
for the spread of a mutant with mechanical vector trans-
mission, but they do not tell us the time frame over
which such spread occurs. For example, it would be
useful to know by how much arthropods must increase
(a) (b)
Figure 1. Sexual transmission rate (solid line) and vector transmission rate (dashed line) as a function of viremia,  . The resulting per capita
growth rate based on equation (4) is also plotted (growth rate is negative where is falls below the horizontal axis, meaning that such strains can
never increase in number). Letters ‘A’ and ‘B’ denote the sexually transmitted and vector transmitted genotypes considered in model (5) of the
text. Parameter values: d0 = 1/65, a =1 , v = 100, x =5 , l = 15. Panel (a) – vector transmission is selectively disadvantageous.
b1ðeÞ¼1
4 1 þ tanh 2ðe   8Þ ðÞ ðÞ , bðeÞ¼1
2 1 þ tanh 2ðe   2Þ ðÞ ðÞ , b2 ¼ 0.945. Figure is drawn with the growth rate of ‘B’ less than that of ‘A’ but still
positive for illustrative purposes only. Negative values of rB also readily occur with only slight changes in parameters values. Panel (b) – vector
transmission is selectively advantageous. b1ðeÞ¼3
4 1 þ tanh 2ðe   8Þ ðÞ ðÞ , bðeÞ¼1
2 1 þ tanh 2ðe   2Þ ðÞ ðÞ , b2 = 1.1.
Day et al. Why is HIV not vector-borne?
ª 2008 The Authors
Journal compilation ª 2008 Blackwell Publishing Ltd 1 (2008) 17–27 21the overall transmission rate of HIV if such strains are to
have increased signiﬁcantly in frequency during the per-
iod of time in which HIV has been evolving in humans.
The calculations in Appendix 2 demonstrate that the fac-
tor by which vectors must increase the overall transmis-
sion rate of HIV, in order for the relative frequency of
the mutant, p/(1 ) p), to increase by a factor of K over a
period of T years, is given by
1   e ðrAþd0ÞsA
1   e ðlnKþðrAþd0ÞTÞsB=T 1 þ
lnK
rA þ d0 ðÞ T
  
: ð7Þ
All parameters in equation (7) can be estimated except K,
T, and sB (Appendix 2), yielding Fig. 2.
First, note that changes in K (the amount of increase
that must occur for evolutionary change to be deemed
‘signiﬁcant’) have very little effect on predictions (Fig. 2).
Therefore, we can view any of these curves as general
requirements for signiﬁcant evolution of vector transmis-
sion to have occurred during the past 30 to 50 years.
Also, as expected, the curves are decreasing, reﬂecting the
fact that a smaller beneﬁt of vector transmission is
required to generate signiﬁcant evolution if evolution has
longer to act. More interestingly we can see that, if the
increased viremia that allows for vector transmission also
results in the development of AIDS after only 5 years as
opposed to 8 years, then arthropods would need to cause
a doubling of HIV transmission rate for appreciable evo-
lution to have occurred. On the other hand, if increased
viremia results in the development of AIDS after only
1 year, then arthropods would need to increase HIV
transmission rate by 5- or 6-fold for appreciable evolution
to have occurred. Unfortunately, there are currently no
estimates available of these parameters, but these calcula-
tions nevertheless suggest that signiﬁcant mechanical
transmission could have evolved within the last 30–
50 years under biologically plausible conditions. There-
fore, the lack of vector transmission in HIV cannot
immediately be attributed to an insufﬁcient evolutionary
history of HIV in humans.
Biological transmission: Although there is no evidence
suggesting that the required genetic variation for
biological transmission is possible in HIV (or any other
retrovirus; Foil and Issel 1991; Kuno 2004; Kuno and
Chang 2005; Webb et al. 1989), it is nevertheless instruc-
tive to consider whether there might also be reasons
associated with the nature and strength of selection for
why such transmission has not evolved.
Equation (5) can again be used in this context, with
equation (4) again deﬁning the per capita growth rate for
different strains of HIV. Biological transmission need not
require an increased viremia in humans, however, because
the pathogen would replicate to transmissible levels once
in the arthropod vector. As a result, strains that are capa-
ble of biological vector transmission need not result in
the more rapid development of AIDS. Without some
associated cost, however, biological vector transmission
would clearly enhance the growth rate of HIV and thus
would readily evolve. Thus, if an absence of such trans-
mission is to be explained in terms of selection (as
opposed to an explanation based on a lack of genetic var-
iation) then there must be some associated cost.
There are at least two biologically plausible mechanisms
through which such a cost might arise. First, effective bio-
logical vector transmission might require evolutionary
changes that reduce HIVs capacity for sexual transmission.
In this case, the cost stems from an evolutionary trade-off
between these two transmission routes. The sexually
transmitted form would have a growth rate deﬁned by
rA þ d0 ¼ xb 1   e ðrAþd0Þs
  
ð8aÞ
whereas the vector-transmitted form would have a growth
rate deﬁned by
rB þ d0 ¼ x
va2b1b2
l
1   e ðrBþd0Þs
  
: ð8bÞ
The parameter values in equations (8) could readily be
such that the growth rate of the vector-transmitted strain
was less than that of the sexually transmitted strain. There
is, however, no a priori reason why this would be
expected rather than the reverse. Therefore, it does not
provide a very compelling answer as to why biological
Figure 2. The factor by which vectors must increase the overall
transmission rate of HIV in order for a vector transmissible virus to
increase in relative frequency by a factor of K, as a function of the
amount of time over which evolution occurs (between 30 and
50 years for HIV in humans). Solid lines assume that the increased
viremia caused by the vector-transmissible virus decreases the time
until the development of AIDS from sA =8t osB = 5 years. Dashed
lines assume a reduction from sA =8t osB = 1 year. The parameter K
has very little effect over several orders of magnitude, meaning that
the beneﬁt of vector transmission required for it to evolve over 30–
50 years is determined largely by the value of sB.
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that it is absent in all other retroviruses as well.
The second way in which a cost of biological transmis-
sion might arise is through a conﬂict between natural
selection acting on transmission of HIV between hosts,
and natural selection acting on the virus’ replicative
capacity within a host. It is well documented in HIV (and
other retroviruses) that extensive genetic variation arises
within an infected host via mutation. If vector-transmissi-
ble strains suffer a cost in terms of their replicative ability
within humans, then this within-host natural selection
acting against vector transmission might be enough to
prevent its spread.
Modeling the evolutionary consequences of this in HIV
is difﬁcult because each infected human will harbor a
suite of genetic variants, some of which will be better at
exploiting the human host. This will cause evolutionary
change in the genetic composition of HIV within the
infected individuals. At the same time, this suite of strains
is also being transmitted to new hosts via sexual contact
and potentially vector transmission. The assumption of
the above hypothesis is then that the strains that are bet-
ter able to transmit to new hosts via vector transmission
are not the ones best able to compete for resources within
a host.
The simplest way to abstract these processes into a
tractable model that still retains the fundamental pro-
cesses at work is to make an assumption of superinfec-
tion. Speciﬁcally, we suppose that humans almost always
harbor only a single strain, but occasionally new strains
arise by mutation. When such a mutation occurs, the
mutant then either takes over the host or dies out instan-
taneously, resulting in a single strain infection once again
(Levin and Pimentel 1981; Nowak and May 1994). In
keeping with our earlier notation we will use B to denote
the vector-transmissible form, and A to denote the form
best able to compete within a host and thus to transmit
sexually.
Letting l be the rate at which new mutations arise
within an infected host, turning either an A pathogen
into a B pathogen or vice versa, and using ri ﬁ j to
denote the probability that an i mutant so produced will
take over a host originally infected with type j, where i
and j are either A or B, model (5) can be extended to
yield (Day and Proulx 2004; Day and Gandon 2006)
dp
dt
¼ p 1   p ðÞ rB   rA ðÞ þ l 1   p ðÞ rA!B   lprB!A ð9Þ
with rA and rB again given by equations (6). The hypothe-
sis under consideration supposes that within-host compe-
tition always favors the sexually transmitted form, and
thus we take rA ﬁ B = 0 in equation (9). In this case,
there are then two possible evolutionary outcomes. First,
if rB ) rA > lrB ﬁ A, then the frequency of vector trans-
mission will ultimately evolve to the equilibrium value
^ p ¼ 1   lrB!A=ðrB   rAÞ ðÞ .On the other hand, if
rB ) rA < lrB ﬁ A, then vector transmission will never
evolve. In other words, if the signiﬁcance of within-host
evolution is large relative to the beneﬁt of vector trans-
mission, then vector transmission will never evolve. This
will be true whenever the mutation rate of the virus is
high (i.e., large l) and when the selective advantage of
sexual transmission in terms of within-host competition
is large. The ﬁrst of these is certainly true of most retrovi-
ruses, although the second requirement is less well docu-
mented. Nevertheless, this might provide a selective
explanation for why no retrovirus appears to have evolved
biological vector transmission.
Discussion
HIV transmission via arthropods was a serious concern
upon the discovery of this virus. Experiments and epide-
miological data have unequivocally demonstrated, how-
ever, that such vector transmission does not occur at any
signiﬁcant level, and various aspects of HIV biology have
been implicated as proximate reasons (Bockarie and Paru
1996). These reasons do not offer an explanation for why
vector transmission has not evolved, however, and as
Weiss (2001) points out, we ought to seriously consider
whether such evolution might occur in the future (for a
summary, see Table 1).
Existing data suggest that the lack of mechanical vector
transmission in HIV is not due to genetic constraints.
While ecological constraints, such as number of vectors
and biting rates, may limit vector transmission in certain
areas, these constraints would likely not explain why HIV
has not evolved this form of transmission in areas where
vector-borne diseases (e.g. malaria) are endemic. Rather,
there must presumably be a reason why such transmission
is selectively disadvantageous in HIV. The calculations
presented above offer one possibility. Effective mechanical
vector transmission can be brought about only through
the evolution of higher levels of viremia, and this also
results in a more rapid onset of AIDS. This reduces the
duration over which such strains can be transmitted from
an infected human, more than is made up for by the
occurrence of vector transmission. It also remains possible
that insufﬁcient time has elapsed for the evolution of vec-
tor transmission to occur, but our calculations suggest
that this is not a very compelling possibility.
On the other hand, existing data is largely consistent
with the hypothesis that biological vector transmission
has not evolved in HIV because of genetic constraints. At
the same time, it is not possible to rule out a selective
explanation instead. In particular, if there is a genetic
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lication in arthropod vectors, then a conﬂict between
selection favoring effective replication within humans,
and selection favoring arthropod transmission between
humans can readily prevent biological transmission from
evolving. This is particularly likely when the mutation
rate of the virus is high, and thus might provide an expla-
nation for the lack of biological vector transmission in all
retroviruses.
Our analysis might also be extended to include other
forms of transmission, for instance needle transmission
(see Bruneau et al. 1997 for the efﬁciency of needle
exchange programs). Several evolutionary consequences of
this are possible depending both on the level of viremia
required for such transmission to occur and the resulting
transmission rate. For instance, if needle transmission can
be achieved with a lower viremia than sexual transmis-
sion, and if this leads to a sufﬁciently high transmission
rate, less virulent strains could be favored. Conversely, if
needle transmission requires a high viremia and leads to a
sufﬁciently high transmission rate, more virulent strains
would be favored. The only situation in which enhanced
needle use could lead to the evolution of vector-borne
transmission would be if effective needle transmission
requires a viremia close to that of vector-borne transmis-
sion, while leading to a much higher transmission rate
than vector-borne transmission. This way, strains with
high viremia could be maintained in the population
through needle transmission, and vector-borne transmis-
sion would then occur largely as a byproduct.
Our conclusions in this article are necessarily specula-
tive, but such speculation is a necessary part of the initial
stages of any research. One of our aims is to stimulate
future research into the evolutionary biology of HIV
transmission. From the results presented here, a number
of different directions might be taken to ground these
evolutionary ideas more ﬁrmly in empirical data. One
possibility would be to examine more closely mechanical
vector transmission in immunodeﬁciency viruses of other
species. For example, more data on the epidemiological
patterns of SIV and its potential for alternative routes of
transmission would be enormously useful. Since SIV is
believed to be at the evolutionary ancestor of HIV, it
would be very interesting to know if the longer evolution-
ary history it has had with its host has resulted in differ-
ent transmission patterns. To the best of our knowledge,
there are no empirical studies testing the potential for
vector transmission of SIV. Another fruitful approach
might be to conduct artiﬁcial selection experiments with
HIV in arthropod tissue culture. Experiments have dem-
onstrated that HIV cannot currently replicate signiﬁcantly
in arthropod cells, but no study to our knowledge has
attempted to select for the evolution of HIV replication
in such cells. One could even imagine doing such experi-
ments with both mammalian and arthropod cell cultures
to determine of the evolutionary trade-off postulated here
actually occurs.
Ultimately, it will require innovative experiments and
empirical studies to push the boundaries of our knowl-
edge of HIV, and the use of evolutionary biology as a
powerful tool for designing sensible intervention strate-
gies. These kinds of studies are beginning to appear for
other aspects of HIV biology (e.g., see Mu ¨ller et al. 2006
for an interesting evolutionary analysis of HIV virulence)
but more work on transmission biology would be useful.
For example, if further empirical research validated the
hypothesis presented here, that mechanical vector trans-
mission has not evolved because of its associated mortal-
Table 1. Main conclusions of the study
Evidence of capability
of HIV for vector
transmission
Evidence of vector
transmission in
related viruses
Evidence of genetic
constraint
Why a lack of vector
transmission?
Mechanism
of vector
transmission
Mechanical; vector
acts solely as a
means of physical
transport of viral
particles
HIV remains viable for
considerable time in
ticks
(Humphrey-Smith
and Chastel 1988;
Humphrey-Smith
et al. 1993) and
C. hemipterus
(Webb et al. 1989).
In Bovine leukemia
virus, Friend murine
leukemia virus,
equine infectious
anemia virus (Foil
and Issel 1991;
Humphrey-Smith
et al. 1993).
Data not consistent
with a genetic
constraint.
Selectively
disadvantageous
since it requires
higher levels of
viremia, resulting in
faster onset of AIDS.
Biological; virus
replicates within the
vector
Little evidence of
replication within
potential vectors
(Srinivasan et al.
1987).
No evidence (Foil and
Issel 1991; Kuno
2004; Kuno and
Chang 2005; Webb
et al. 1989)
Data is consistent
with a genetic
constraint.
Genetic trade-off
between replication
in human host and
insect vector.
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how we attempt to stop the spread of HIV. Strategies
such as condom use, while beneﬁcial for reducing the
extent of sexual transmission, could thereby enhance the
relative beneﬁt of vector transmission, potentially resulting
in the evolution of this new route of transmission. The
use of antibiotics against bacterial pathogens has clearly
brought home the fact that pathogens can readily evolve
the means to circumvent our control measures, and there
is no reason to expect things to be any different for other
control measures. The use of antiviral medication, on the
other hand, not only reduces sexual transmission but also
the level of viremia, and therefore would presumably not
move the selective balance more towards vector transmis-
sion. It is only by asking these kinds of questions, how-
ever, that we will have a chance at preventing adverse
future outcomes.
Finally, the question of biological vector transmission
addressed here is really a special case of the more gen-
eral question of the evolution of a pathogen’s host
range. Why do some pathogens have a relatively broad
taxonomic host range while others are much more con-
servative? This continues to be an interesting and
important question in the evolutionary ecology of para-
sites (Poulin 2007) and there are some theoretical
results predicting when we might expect different out-
comes (Gandon 2004). From the standpoint of human
diseases this is also clearly an important question since
emerging diseases, such as pandemic inﬂuenza, are
precisely instances in which a pathogen evolves a differ-
ent host range. A better understanding of the evolu-
tionary biology of parasite host ranges is an important
goal for future research.
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Appendix 1 – Derivation of per capita growth rate
Model (2) of the main text predicts an eventual expo-
nential increase in the number of HIV-positive people
(assuming overall transmission rates are high enough).
We can calculate the rate of increase, r, in the follow-
ing way. First, because the population dynamics of the
vector occur on a shorter timescale than that for HIV
infection, we can treat the variable w as though it is
always maintained in quasi-equilibrium. Setting equa-
tion (2) equal to zero, the quasi-equilibrium value is
given by
wðtÞ 
vab1
l
Z 1
0
yðs;tÞds: ðA1-1Þ
Thus, model (2) can be simpliﬁed to the single equation
@yða;tÞ
@t
¼ 
@yða;tÞ
@a
  dðaÞyða;tÞð A1-2Þ
with boundary condition yð0;tÞ¼x va2b1b2
l þ b
  
R 1
0 yðs;tÞds. Equation (A1-2) can then be solved by sepa-
ration of variables. In particular, we postulate a solution
of the form y(a, t)=A(a)T(t). Substituting this into
(A1-2) then yields
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T0=T ¼  A0=A   d
:
Given that exponential growth at rate r occurs, we have
T’/T = r, and therefore A(a) satisﬁes the equation
) (r + d)=A¢/A. This has the solution
AðaÞ¼A0 exp  
Z a
0
ðr þ dðsÞÞds
  
: ðA1-3Þ
Substituting solution (A1-3) into the boundary condition
for equation (A1-2) we then obtain
1 ¼ x
va2b1b2
l
þ b
   Z 1
0
e
 
R s
0 ðrþdðzÞÞdzds: ðA1-4Þ
Finally, making use of (3) from the main text, equation
(A1-4) simpliﬁes as
1 ¼ x
va2b1b2
l
þ b
   Z s
0
e ðrþd0Þsds
or
r þ d0 ¼ x
va2b1b2
l
þ b
  
1   e ðrþd0Þs
  
: ðA1-5Þ
Equation (A1-5) implicitly deﬁnes the growth rate, r,a sa
function of the epidemiological parameters.
If we want to take into account the fact that, depend-
ing on the age of infection, hosts might be more or less
infectious we get
1 ¼ x
va2b2
l
Z s
0
b1ðsÞe ðrþd0Þsds þ
Z s
0
bðsÞe ðrþd0Þsds
  
ðA1-6Þ
In this case solving the integration requires a numerical
approximation. Also, we need to make an extra assump-
tion to link age of infection and infectious state (both for
vector-borne and sexual transmission).
If we take a decreasing function of the shape b1e ka
and be ka, where k is a positive constant indicating the
speed of decrease in transmission, we can write:
1 ¼ x
va2b2
l
b1
Z s
0
e ðrþd0þkÞsds þ b
Z s
0
e ðrþd0þkÞsds
  
ðA1-7Þ
We thus end-up with almost the same expression as
before:
r þ d0 þ k ¼ x
va2b1b2
l
þ b
  
1   e ðrþd0Þs
  
ðA1-8Þ
To summarize, if we assume the decrease in transmission
can be approximated by an exponential function, the
same analysis holds by simply modifying the value of, d0.
Appendix 2 – Analysis of the time frame of
mutant spread
First, equations (6) can be combined to obtain
va2b1b2
bl
þ 1
  
¼
rB þ d0
1   e ðrBþd0ÞsB
 
rA þ d0
1   e ðrAþd0ÞsA ðA2-1Þ
where the quantity on the left-hand side of (A2-1) is the
factor by which arthropods must increase overall HIV
transmission to yield a given value of the per capita growth
rate, rB. Furthermore, from equation (5) it can be shown
that the relative frequency of the mutant allele, h = p/
(1 ) p) changes exponentially over time, according to
dh
dt
¼ rB   rA ðÞ h: ðA2-2Þ
Therefore, the value of rB   rA ðÞ required for h to
increase by a factor of K in T time units is (ln K)/T.A sa
result, we can express the required value of rB as a func-
tion of K, T, and rA as rB = (ln K)/T + rA. Substituting
this into the right-hand side of equation (A2-1) yields
1   e ðrAþd0ÞsA
1   e ðlnKþðrAþd0ÞTÞsB=T 1 þ
lnK
rA þ d0 ðÞ T
  
: ðA2   3Þ
Lastly, we can estimate rA from existing data. The number
of HIV-infected people in the world has increased from
approximately 10 million to approximately 35 million in
the 11 years between 1991 and 2002 (UNAIDS 2006).
Assuming an exponential increase, this yields a value of
rA   0.114. Further, using a life expectancy of 65 years,
we can estimate d0 = 1/65, and also sA   8 years as the
rough time elapsed between HIV infection and the devel-
opment of AIDS. This leaves the parameters K, T, and sB
when plotting Fig. 2. The parameter K is seen to have
very little effect over several orders of magnitude (Fig. 2).
Therefore, the beneﬁt of vector transmission (in terms of
transmission rate) required for it to evolve within 30–
50 years is determined largely by the value of sB, which is
the time elapsing before the onset of AIDS for the vector-
transmissible strain.
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